Annual Net Income
-$109.96 M
-$24.07 M-28.02%
December 1, 2024
Summary
- As of February 22, 2025, VKTX annual net profit is -$109.96 million, with the most recent change of -$24.07 million (-28.02%) on December 1, 2024.
- During the last 3 years, VKTX annual net income has fallen by -$54.97 million (-99.97%).
- VKTX annual net income is now -75114.09% below its all-time high of -$146.20 thousand, reached on December 31, 2013.
Performance
VKTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$35.42 M
-$10.48 M-42.01%
December 1, 2024
Summary
- As of February 22, 2025, VKTX quarterly net profit is -$35.42 million, with the most recent change of -$10.48 million (-42.01%) on December 1, 2024.
- Over the past year, VKTX quarterly net income has dropped by -$10.81 million (-43.94%).
- VKTX quarterly net income is now -2649.27% below its all-time high of $1.39 million, reached on December 31, 2014.
Performance
VKTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$109.96 M
-$10.81 M-10.90%
December 1, 2024
Summary
- As of February 22, 2025, VKTX TTM net profit is -$109.96 million, with the most recent change of -$10.81 million (-10.90%) on December 1, 2024.
- Over the past year, VKTX TTM net income has dropped by -$24.07 million (-28.02%).
- VKTX TTM net income is now -98965.77% below its all-time high of -$111.00 thousand, reached on December 31, 2012.
Performance
VKTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
VKTX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.0% | -43.9% | -28.0% |
| 3 y3 years | -100.0% | -186.6% | -100.0% |
| 5 y5 years | -326.6% | -375.4% | -326.6% |
VKTX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -186.6% | at low | -100.0% | at low |
| 5 y | 5-year | -326.6% | at low | -375.4% | at low | -326.6% | at low |
| alltime | all time | <-9999.0% | at low | -2649.3% | at low | <-9999.0% | at low |
Viking Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$109.96 M(+28.0%) | -$35.42 M(+42.0%) | -$109.96 M(+10.9%) |
| Sep 2024 | - | -$24.94 M(+12.1%) | -$99.15 M(+2.5%) |
| Jun 2024 | - | -$22.25 M(-18.7%) | -$96.75 M(+3.2%) |
| Mar 2024 | - | -$27.36 M(+11.2%) | -$93.72 M(+9.1%) |
| Dec 2023 | -$85.89 M(+24.7%) | -$24.61 M(+9.2%) | -$85.89 M(+6.2%) |
| Sep 2023 | - | -$22.53 M(+17.2%) | -$80.85 M(+9.1%) |
| Jun 2023 | - | -$19.23 M(-1.6%) | -$74.09 M(+2.5%) |
| Mar 2023 | - | -$19.53 M(-0.1%) | -$72.30 M(+5.0%) |
| Dec 2022 | -$68.87 M(+25.2%) | -$19.56 M(+24.0%) | -$68.87 M(+11.7%) |
| Sep 2022 | - | -$15.77 M(-9.5%) | -$61.66 M(+4.3%) |
| Jun 2022 | - | -$17.43 M(+8.3%) | -$59.13 M(+3.6%) |
| Mar 2022 | - | -$16.10 M(+30.3%) | -$57.08 M(+3.8%) |
| Dec 2021 | -$54.99 M(+39.2%) | -$12.36 M(-6.7%) | -$54.99 M(+2.6%) |
| Sep 2021 | - | -$13.24 M(-13.9%) | -$53.58 M(+8.0%) |
| Jun 2021 | - | -$15.38 M(+9.8%) | -$49.63 M(+13.3%) |
| Mar 2021 | - | -$14.01 M(+28.0%) | -$43.82 M(+10.9%) |
| Dec 2020 | -$39.49 M(+53.2%) | -$10.95 M(+17.9%) | -$39.49 M(+9.7%) |
| Sep 2020 | - | -$9.29 M(-3.0%) | -$36.00 M(+11.0%) |
| Jun 2020 | - | -$9.57 M(-1.2%) | -$32.44 M(+6.2%) |
| Mar 2020 | - | -$9.69 M(+30.0%) | -$30.54 M(+18.5%) |
| Dec 2019 | -$25.78 M(+16.8%) | -$7.45 M(+30.0%) | -$25.78 M(+9.4%) |
| Sep 2019 | - | -$5.73 M(-25.3%) | -$23.57 M(-3.6%) |
| Jun 2019 | - | -$7.67 M(+55.8%) | -$24.44 M(+4.3%) |
| Mar 2019 | - | -$4.92 M(-6.0%) | -$23.44 M(+6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$22.06 M(+7.2%) | -$5.24 M(-20.6%) | -$22.06 M(+5.5%) |
| Sep 2018 | - | -$6.60 M(-1.1%) | -$20.91 M(+2.5%) |
| Jun 2018 | - | -$6.67 M(+87.9%) | -$20.41 M(+7.9%) |
| Mar 2018 | - | -$3.55 M(-13.1%) | -$18.91 M(-8.1%) |
| Dec 2017 | -$20.58 M(+39.7%) | -$4.08 M(-33.0%) | -$20.58 M(+2.2%) |
| Sep 2017 | - | -$6.10 M(+17.9%) | -$20.14 M(+12.8%) |
| Jun 2017 | - | -$5.17 M(-1.0%) | -$17.85 M(+9.0%) |
| Mar 2017 | - | -$5.22 M(+43.3%) | -$16.37 M(+11.1%) |
| Dec 2016 | -$14.73 M(-37.1%) | -$3.64 M(-4.3%) | -$14.73 M(-8.9%) |
| Sep 2016 | - | -$3.81 M(+3.1%) | -$16.18 M(-5.4%) |
| Jun 2016 | - | -$3.69 M(+2.9%) | -$17.11 M(-19.6%) |
| Mar 2016 | - | -$3.59 M(-29.5%) | -$21.28 M(-9.1%) |
| Dec 2015 | -$23.40 M(+6.9%) | -$5.09 M(+7.5%) | -$23.40 M(+38.3%) |
| Sep 2015 | - | -$4.74 M(-39.8%) | -$16.92 M(+35.9%) |
| Jun 2015 | - | -$7.87 M(+37.7%) | -$12.45 M(-54.5%) |
| Mar 2015 | - | -$5.71 M(-511.1%) | -$27.37 M(+25.1%) |
| Dec 2014 | -$21.88 M(>+9900.0%) | $1.39 M(-630.7%) | -$21.88 M(-6.0%) |
| Sep 2014 | - | -$261.80 K(-98.9%) | -$23.27 M(+1.1%) |
| Jun 2014 | - | -$22.78 M(+9853.2%) | -$23.01 M(+9057.1%) |
| Mar 2014 | - | -$228.90 K(+921.9%) | -$251.30 K(+82.1%) |
| Dec 2013 | -$146.20 K | - | - |
| Jun 2013 | - | -$22.40 K(+387.0%) | -$138.00 K(+19.4%) |
| Mar 2013 | - | -$4600.00(-95.9%) | -$115.60 K(+4.1%) |
| Dec 2012 | - | -$111.00 K | -$111.00 K |
FAQ
- What is Viking Therapeutics annual net profit?
- What is the all time high annual net income for Viking Therapeutics?
- What is Viking Therapeutics annual net income year-on-year change?
- What is Viking Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Viking Therapeutics?
- What is Viking Therapeutics quarterly net income year-on-year change?
- What is Viking Therapeutics TTM net profit?
- What is the all time high TTM net income for Viking Therapeutics?
- What is Viking Therapeutics TTM net income year-on-year change?
What is Viking Therapeutics annual net profit?
The current annual net income of VKTX is -$109.96 M
What is the all time high annual net income for Viking Therapeutics?
Viking Therapeutics all-time high annual net profit is -$146.20 K
What is Viking Therapeutics annual net income year-on-year change?
Over the past year, VKTX annual net profit has changed by -$24.07 M (-28.02%)
What is Viking Therapeutics quarterly net profit?
The current quarterly net income of VKTX is -$35.42 M
What is the all time high quarterly net income for Viking Therapeutics?
Viking Therapeutics all-time high quarterly net profit is $1.39 M
What is Viking Therapeutics quarterly net income year-on-year change?
Over the past year, VKTX quarterly net profit has changed by -$10.81 M (-43.94%)
What is Viking Therapeutics TTM net profit?
The current TTM net income of VKTX is -$109.96 M
What is the all time high TTM net income for Viking Therapeutics?
Viking Therapeutics all-time high TTM net profit is -$111.00 K
What is Viking Therapeutics TTM net income year-on-year change?
Over the past year, VKTX TTM net profit has changed by -$24.07 M (-28.02%)